Apollo Endosurgery, Inc.
APEN
APEN was delisted on the 3rd of April, 2023.
10 hedge funds and large institutions have $21.5M invested in Apollo Endosurgery, Inc. in 2017 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
17% more capital invested
Capital invested by funds: $18.3M → $21.5M (+$3.14M)
11% more funds holding
Funds holding: 9 → 10 (+1)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO)
Austin,
Texas
|
+$2.2M |
| 2 |
TAF
Tredje AP-fonden
Se-111 91 Stockholm,
Sweden
|
+$540K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$191K |
| 4 |
BlackRock
New York
|
+$916 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$496 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$31.7K |
| 2 |
HDIM
Hanson & Doremus Investment Management
Burlington,
Vermont
|
-$13 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NHAS
1
Novo Holdings A/S
Hellerup,
Denmark
| $18.2M | – | – | – |
|
|
UOTTAIMCU
2
University of Texas/Texas AM Investment Management Co (UTIMCO)
Austin,
Texas
| $2.16M | +$2.2M | +172,499 | New |
|
|
TAF
3
Tredje AP-fonden
Se-111 91 Stockholm,
Sweden
| $851K | +$540K | +42,408 | +125% |
|
|
BCM
4
Bridgeway Capital Management
Houston,
Texas
| $190K | +$191K | +15,000 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $13K | -$31.7K | -2,490 | -71% |
|
|
HDIM
6
Hanson & Doremus Investment Management
Burlington,
Vermont
| $1K | -$13 | -1 | -2% |
|
|
7
BlackRock
New York
| $1K | +$916 | +72 | New |
|
8
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | +$38 | +3 | New |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| – | +$496 | +39 | New |
|
APEN Hedge Fund Activity: Q1 2017 in Review
10 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q1 2017, worth a combined $21.5M — up 17% from $18.3M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new APEN positions and 3 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was University of Texas/Texas AM Investment Management Co (UTIMCO), opening a new position worth an estimated $2.2M. The largest seller was UBS Group, cutting an estimated $31.7K.
- 10 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q1 2017, up from 9 in Q4 2016.
- Funds reported $21.5M of Apollo Endosurgery, Inc. stock for Q1 2017, up 17% quarter-over-quarter.
- 5 funds opened new Apollo Endosurgery, Inc. positions in Q1 2017 and 3 closed out, a net change of +2 holders.
- The largest Apollo Endosurgery, Inc. buyer in Q1 2017 was University of Texas/Texas AM Investment Management Co (UTIMCO), an estimated $2.2M added.
- The largest Apollo Endosurgery, Inc. seller in Q1 2017 was UBS Group, an estimated $31.7K sold.
Based on aggregated 13F filings for Q1 2017.